Walgreens Boots Alliance NASDAQ: WBA is a global leader in integrated healthcare, pharmacy, and retail. The company recently released its earnings report for the third quarter of 2024, raising questions about its ability to navigate a challenging market environment and achieve sustainable growth.
Shares in Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) tanked after hours in the wake of news the pharmacy chain plans to close a significant number of its US pharmacies due to mounting challenges in its retail business. CEO Tim Wentworth indicated that the current pharmacy model is unsustainable, citing ongoing issues such as reduced reimbursement rates from pharmacy benefit managers.
Major U.S. equities indexes posted moderate gains on Thursday ahead of Friday's Personal Consumption Expenditures (PCE) report.
Walgreens Boots Alliance reported slow sales growth of 2.6% and lowered full-year earnings guidance to $2.80 to $2.95 per share. The company expects to close stores to cut costs and improve profits.
Walgreens will be closing a substantial number of its more than 8,600 U.S. stores over the next three years.
Challenges in the retail environment and the pharmacy industry have led Walgreens Boots Alliance to consider closing as many as 25% of its U.S. retail stores.
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) shares plunged 25% on Thursday after the pharmacy giant lowered its full-year profit guidance, warned more US store closures are to come, and delivered fiscal third quarter earnings below estimates. For the full year, Walgreens now expects adjusted earnings per share (EPS) in the range of $2.80 to $2.95 from its prior forecast of $3.20 to $3.35 and below the $3.21 expected by analysts.
CVS Health Corp CVS shares are getting crushed because of the terrible earnings report from Walgreens Boot Alliance. Inc. WBA.
Junk bonds issued by Walgreens Boots Alliance Inc. were among the biggest decliners in the high-yield market on Thursday, swept up in the downdraft of a stock that was trading at a 27-year low.
Walgreens recently reported its Q3'24 results (fiscal ends in August), with revenue exceeding but earnings falling short of our expectations. The company reported revenue of $36.4 billion and adjusted earnings of $0.63 per share, compared to our estimates of $36 billion, and $0.75, respectively.
Walgreens announced it will be cutting its profit forecast for the fiscal 2024 year and closing more stores across the US in its latest attempt to deal with a "difficult operating environment."
Walgreens (NASDAQ: WBA ) stores will be closing as the company's CEO announces that “imminent” changes need to happen at the struggling pharmacy chain. According to CEO Tim Wentworth, Walgreens has continued to have trouble courting customers as they are resistant to current prices.